Last reviewed · How we verify

HSS 3% — Competitive Intelligence Brief

HSS 3% (HSS 3%) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic agent / Hypertonic saline. Area: Neurology / Critical Care.

phase 3 Osmotic agent / Hypertonic saline Neurology / Critical Care Small molecule Live · refreshed every 30 min

Target snapshot

HSS 3% (HSS 3%) — Ministry of Health, Spain. HSS 3% is a hypertonic saline solution that draws fluid from tissues into the vascular space through osmotic gradient, reducing intracranial pressure and cerebral edema.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
HSS 3% TARGET HSS 3% Ministry of Health, Spain phase 3 Osmotic agent / Hypertonic saline
NaCl 3% NaCl 3% Raphaelle Jaquet-Pilloud phase 3 Osmotic agent / Hypertonic saline

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic agent / Hypertonic saline class)

  1. Ministry of Health, Spain · 1 drug in this class
  2. Raphaelle Jaquet-Pilloud · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). HSS 3% — Competitive Intelligence Brief. https://druglandscape.com/ci/hss-3. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: